New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.74-0.49 (-1.13%)
At close: 04:00PM EST
42.60 -0.14 (-0.33%)
After hours: 05:42PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
11,470,000
9,913,000
10,735,000
9,823,000
Cost of revenue
3,790,000
3,510,000
3,181,000
2,883,000
Gross profit
7,680,000
6,403,000
7,554,000
6,940,000
Operating expenses
Research development
1,170,000
1,143,000
1,174,000
1,113,000
Selling general and administrative
4,233,000
3,787,000
3,941,000
3,569,000
Total operating expenses
6,146,000
5,719,000
5,814,000
5,281,000
Operating income or loss
1,534,000
684,000
1,740,000
1,659,000
Interest expense
350,000
361,000
473,000
241,000
Total other income/expenses net
74,000
-405,000
-612,000
-1,000
Income before tax
1,264,000
-79,000
687,000
1,422,000
Income tax expense
106,000
2,000
-4,013,000
-249,000
Income from continuing operations
1,156,000
-82,000
4,700,000
1,671,000
Net income
1,156,000
-82,000
4,700,000
1,671,000
Net income available to common shareholders
1,101,000
-115,000
4,700,000
1,671,000
Basic EPS
-
-0.12
3.38
1.21
Diluted EPS
-
-0.12
3.33
1.19
Basic average shares
-
1,416,700
1,391,500
1,381,000
Diluted average shares
-
1,416,700
1,410,600
1,401,400
EBITDA
-
1,405,000
2,171,000
2,557,000